Home/Mucommune/Sam Lai, Ph.D.
SL

Sam Lai, Ph.D.

Founder & Interim CEO

Mucommune

Mucommune Pipeline

DrugIndicationPhase
MM009Bacterial vaginosisPre-Clinical
MM011UndisclosedDiscoverY
MM012UndisclosedDiscoverY
MM017UndisclosedDiscoverY
MM018UndisclosedDiscoverY
MM010PEG immunogenicityDiscoverY
MM014in vivo CAR-T for solid tumorsDiscoverY
MM016UndisclosedDiscoverY